Save
Email
Print
Share
RSS
Drug Shows Surprising Efficacy as Treatment for Chronic Leukemia, Mantle Cell Lymphoma
Clinical studies suggest
that the novel, targeted
agent ibrutinib shows real
potential is a safe,
effective, treatment for
... > full story
Promising Results in Treating a Lymphoma in Young People
Patients with a type of
cancer known as primary
mediastinal B-cell lymphoma
who received infusions of
chemotherapy, but who did
not have radiation therapy
... > full story
New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells
Scientists have created a
unique monoclonal antibody
that can effectively reach
inside a cancer cell. ... > full story
Discovery of New Class of Damage-Prone DNA Regions Could Lead to Better Cancer Treatments
Cancer is thought to arise
from DNA damage at fragile
sites in the genome. A new
study reveals a new class of
fragile sites that
... > full story
- Drug Shows Surprising Efficacy as Treatment for Chronic Leukemia, Mantle Cell Lymphoma
- Promising Results in Treating a Lymphoma in Young People
- New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells
- Discovery of New Class of Damage-Prone DNA Regions Could Lead to Better Cancer Treatments
Browse News Stories
1 to 10 of 317 stories
view headlines only
-
Novel Drug Shuts Down Master Protein Key to Lymphoma
August 1, 2013 — Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses. The study sets the stage for testing the drug in clinical ... > full story -
Higher Cancer Incidences Found in Regions Near Refineries and Plants That Release Benzene
July 29, 2013 — The incidence of a particular type of blood cancer is significantly higher in regions near facilities that release the chemical benzene into the ... > full story -
Intestinal Bacteria Linked to White Blood Cell Cancer
July 16, 2013 — Researchers have discovered that specific types of bacteria that live in the gut are major contributors to lymphoma, a cancer of the white blood cells that are part of the human immune ... > full story -
Research IDs Potential Treatment for Deadly, HIV-Related Blood Cancer
June 25, 2013 — Researchers have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with ... > full story -
Human and Canine Lymphomas Share Molecular Similarities, First Large-Scale Comparison Shows
June 25, 2013 — Humans and their pet dogs are close, so close that they both develop a type of cancer called diffuse large B-cell lymphoma. In humans it’s the most common lymphoma subtype while in dogs, ... > full story -
TCE Exposure Linked to Increased Risk of Some Cancers
May 30, 2013 — Trichloroethylene (TCE) exposure has possible links to increased liver cancer risk, and the relationship between TCE exposure and risks of cancers of low incidence and those with confounding by ... > full story -
Radioactive Nanoparticles Target Cancer Cells
May 21, 2013 — Researchers have found a way to create radioactive nanoparticles that target lymphoma tumor cells wherever they may be in the ... > full story -
Master Regulator That Drives Majority of Lymphoma Discovered
May 13, 2013 — A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However medical researchers now ... > full story -
Immunotherapy Showed Promising Antileukemia Activity in Pediatric Patients
April 7, 2013 — Researchers using patients' own immune cells in an immunotherapy approach called "anti-CD19 chimeric antigen receptor (CAR) T-cell therapy," achieved responses in children whose acute lymphocytic ... > full story -
Cell Reprogramming to Cure Leukemia and Lymphoma?
April 2, 2013 — Researchers have reprogrammed lymphoma and leukemia cells to halt their malignancy. Resulting cells remained benign even when no longer subjected to treatment and patients were less likely to develop ... > full story
Search ScienceDaily
Number of stories in archives: 140,670
more 
